BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27384265)

  • 1. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
    Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
    Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal Venlafaxine Exposure-Induced Neurocytoarchitectural and Neuroapoptotic Degeneration in Striatum and Hippocampus of Developing Fetal Brain, Manifesting Long-term Neurocognitive Impairments in Rat Offspring.
    Singh KP; Sharma P; Singh M
    Neurotox Res; 2022 Oct; 40(5):1174-1190. PubMed ID: 35819590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D; Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero dimethadione exposure causes postnatal disruption in cardiac structure and function in the rat.
    Aasa KL; Purssell E; Adams MA; Ozolinš TR
    Toxicol Sci; 2014 Dec; 142(2):350-60. PubMed ID: 25239635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
    Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
    BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on congenital cardiac anomalies induced by arsenic exposure before and during maternal pregnancy in fetal rats].
    Lin Y; Zhuang L; Ma H; Wu L; Huang H; Guo H
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):93-7. PubMed ID: 26987204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
    Selmer R; Haglund B; Furu K; Andersen M; Nørgaard M; Zoëga H; Kieler H
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1160-1169. PubMed ID: 27193296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
    Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
    J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
    Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
    Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.
    Capello CF; Bourke CH; Ritchie JC; Stowe ZN; Newport DJ; Nemeroff A; Owens MJ
    J Pharmacol Exp Ther; 2011 Oct; 339(1):275-85. PubMed ID: 21775476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
    JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?
    Ornoy A; Koren G
    Birth Defects Res; 2017 Jul; 109(12):898-908. PubMed ID: 28714608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Utero Exposure to a Cardiac Teratogen Causes Reversible Deficits in Postnatal Cardiovascular Function, But Altered Adaptation to the Burden of Pregnancy.
    Aasa KL; Maciver RD; Ramchandani S; Adams MA; Ozolinš TR
    Toxicol Sci; 2015 Nov; 148(1):155-66. PubMed ID: 26311034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental P-glycoprotein inhibition enhances susceptibility to Di-(2-ethylhexyl)-phthalate induced cardiac malformations in mice: A possibly promising target for congenital heart defects prevention.
    Tang C; Luo C; Hua Y; Zhou K; Duan H; Ma F; Zhang Y; Li Y; Qiu D; Wang C
    PLoS One; 2019; 14(5):e0214873. PubMed ID: 31086358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: A mechanism study.
    Li X; Ye L; Ge Y; Yuan K; Zhang Y; Liang Y; Wei J; Zhao C; Lian QQ; Zhu X; Ge RS
    Placenta; 2016 Mar; 39():125-33. PubMed ID: 26992685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives.
    Horackova H; Karahoda R; Cerveny L; Vachalova V; Ebner R; Abad C; Staud F
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.
    Tan B; Chen L; Yan S; Pan H; Zhang J; Wei H
    Sci Rep; 2024 Jul; 14(1):15167. PubMed ID: 38956425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplacental transfer of venlafaxine evaluated by ex vivo perfusion.
    Hirschmugl B; Wadsack C
    Placenta; 2022 Jan; 117():150-153. PubMed ID: 34894602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.